Makena sales over time

This page will track the quarterly sales of AMAG Pharmaceuticals' Makena, a progestin indicated to reduce the risk of preterm birth. It was acquired through the purchase of Lumara Health's maternal health business for $675 million in late 2014.

Makena Sales